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Abstract. The impact of digitalization on the average glandular doses in 49 
mammographic units participating in the Flemish Breast Cancer Screening Pro-
gram was studied.  Screen-film was changed to direct digital radiography and 
computed radiography in 24 and 25 departments respectively.  Average glandu-
lar doses were calculated before and after digitalization for different PMMA-
phantom thicknesses and for groups of 50 successive patients.  For the transi-
tion from screen-film to computed radiography both phantom and patient dose 
data show a significant increase of dose with digitalization.  For the transition 
from screen-film to direct digital radiography the evolution of the average glan-
dular dose depends on the phantom thickness.  For 20mm PMMA a significant 
increase in dose was found, for 45mm and 70mm PMMA there was a signifi-
cant decrease in dose.  The median average glandular dose of the patient dosim-
etry showed a smaller but significant decrease. 
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1 Introduction 
After a typetesting procedure [1-2] the first digital mammographic units were accept-
ed within the Flemish Breast Cancer Screening Program in 2007.  It is often claimed 
by manufacturers and in the media that “digitalization” in mammography leads to a 
dose reduction.  However over the past 5 years, medical physicists in Flanders en-
countered that for individual mammographic centers the dose is sometimes higher 
after digitalization than before.  Since asymptomatic woman between age 50 and 69 
are systematically screened for breast cancer every two years in Flanders, it is neces-
sary to assure the balance between benefit and the risk of the screening program.  
Therefore it is important to check the impact of the changes in average glandular dose 
caused by digitalization of the screening units on the radiation-induced breast cancer 
risk of the Flemish Breast Cancer Screening Program.   
2 Method 
The impact of digitalization on the average glandular doses was studied in 49 mam-
mographic units participating in the Flemish Breast Cancer Screening Program.  
Screen-film (SF) was changed to direct digital radiography (DR) and computed radi-
ography (CR) in 24 and 25 departments respectively.   
For all centers data regarding the yearly and half yearly physical-technical quality 
assurance test are available, in accordance with the European Guidelines [3-4]. On 
one hand average glandular doses (AGDs) before and after digitalization could be 
calculated for PMMA-phantom thicknesses between 20mm and 70mm applying the 
method of Dance et al. [5] based on automatic exposure control data, combined with 
output and half value layer measurements.   
On the other hand a real patient dose study was performed in all centers after digi-
talization.  Average glandular doses were calculated for a group of at least 50 succes-
sive patients.  A large fraction of the centers conducted also a patient dose study prior 
to digitalization.  Periodic patient dose studies are required by Belgian legislation [6].  
A first registration period ended in the beginning of 2010.  At that time some mam-
mographic centers were already working digital, others were still working conven-
tional.  For each center that digitalized later on, a second patient dose study was re-
quested.   
For each patient dose study, the median of the average glandular doses was plotted 
against the average glandular dose corresponding with the 45mm PMMA-phantom at 
the time.  These data could be represented satisfactory by a linear fit (y=1.066x ± 
0.235, r²=0.738, Fig. 1).    For centers who did not perform patient dosimetry of a 
patient population prior to digitalization, the linear fit was used to deduce the median 
of the average glandular doses for a group of patients from the phantom dose data 
obtained prior to digitalization.   
AGDs before and after digitalization were compared for each mammographic unit 
individually and significance of difference was evaluated by Wilcoxon signed rank 
test (p<0.05).  Mean AGDs were calculated over the different units. 
 
 
Fig. 1. Correlation between the median of the AGDs of a group of 50 patients  
and the AGD of a 45mm PMMA phantom    
3 Results 
Before digitalization there was a large variation in average glandular dose as a func-
tion of phantom-thickness between the 49 mammography units (Fig. 2).  The dose 
differences were mainly due to the brand and type of the screen-film combination.  
For larger compressed breast thicknesses the observed dose differences are also linked 
to the brand and type of the corresponding x-ray units.  Older x-ray units operate at 
Mo/Mo for all thicknesses.  However the automatic exposure control of newer x-ray 
units changes at larger compressed breast thicknesses automatically to other tar-
get/filter combinations and/or higher kilovoltages, which reduces the AGD in such a 
way that the image quality remains acceptable. 
For all CR-systems phantom-doses are quite high and there is a smaller variation in 
doses between the different brands of CR-cassettes (Fig. 3).  This because the auto-
matic exposure controls had to be calibrated close to the acceptable dose limit stated 
in the European Quality Control Protocol in order to reach acceptable image quality 
for small details.   
For DR-systems phantom-doses are generally lower than for CR-systems (Fig. 4) 
and comparable to the lower dose SF-systems.  Only one DR-system operated at a 
dose level lower than the lowest SF-system, this was a mammography unit with a 
photon counting detector instead of an amorphous silicon or amorphous selenium 
detector. 
These trends were also seen in the patient dosimetry, though differences in indi-
vidual breast composition and in the executed compression force have an influence on 
the correlation between phantom en patient dosimetry.   
For the transition from SF to CR (25 screening units) phantom AGD increased sig-
nificantly for 20mm, 45mm and 70mm PMMA in nearly all mammographic units 
(Fig. 5, Fig. 6, Fig. 7, Table 1).  The median AGD of a dose study of 50 successive 
patients was also significantly higher after digitalization from SF to CR (Fig. 8, Table 
1).  
For the transition from SF to DR (24 screening units) the evolution of the AGD 
depends on the phantom thickness.  For 20mm PMMA a significant increase in dose 
was found (Fig. 5, Table 2).  For 45mm and 70mm PMMA there was a significant 
decrease in dose (Fig. 6, Fig. 7, Table 2).  The median AGD of a dose study of 50 
successive patients showed a smaller but significant decrease after digitalization from 
SF to DR (Fig. 8, Table 2).   
 Fig. 2. Screen-film phantom dosimetry: AGD versus phantom thickness averaged over different 
brands and different screen-film combination types 
 
Fig. 3. Computed radiography phantom dosimetry: AGD versus phantom thickness averaged 
over different brands and different imaging plate types 
 
Fig. 4. Direct digital radiography phantom dosimetry: AGD versus phantom thickness averaged 
over different brand s and different models of mammography equipment 
 Fig. 5. Phantom dosimetry at 
20mm PMMA: AGD before 
and after digitalization in the 
mammographic units of the 
study 
 
 
Fig. 6. Phantom dosimetry at 
45mm PMMA: AGD before 
and after digitalization 
 
 
Fig. 7. Phantom dosimetry at 
70mm PMMA: AGD before 
and after digitalization 
 
 Fig. 8. Median AGD of a 
patient dose study of 50 
successive patients before 
and after digitalization 
 
 
Table 1. Statistical analysis of the transition from SF to CR   
 
Table 2. Statistical analysis of the transition from SF to DR   
 
4 Discussion 
It is a misconception that digitalization in mammography always leads to a dose re-
duction.  Our results demonstrate that the transition from screen-film mammography 
to computed radiography on average in fact leads to a 38% higher AGD for an aver-
age patient.  This higher dose is necessary to reach an acceptable image quality level 
for small details.  In contrast a reduction of 12% in AGD was achieved on average for 
an average patient with a transition from screen-film mammography to direct digital 
radiography.  We believe a stronger dose reduction for the transition from SF to DR 
can be accomplished by optimizing the automatic exposure control of the DR sys-
SF
mean
CR
mean 
normalized dose 
difference
p*
AGD @20 mm PMMA (mGy) 0.42 0.60 43% 0.000
AGD @45 mm PMMA (mGy) 1.45 1.97 36% 0.000
AGD @70 mm PMMA (mGy) 3.98 5.21 31% 0.000
median AGD patient dosimetry (mGy) 1.53 2.11 38% 0.000
* Wilcoxon Signed Ranks Test
SF
mean
DR
mean 
normalized dose 
difference
p*
AGD @20 mm PMMA (mGy) 0.41 0.61 49% 0.000
AGD @45 mm PMMA (mGy) 1.45 1.16 -20% 0.000
AGD @70 mm PMMA (mGy) 3.53 2.43 -31% 0.001
median AGD patient dosimetry (mGy) 1.50 1.32 -12% 0.032
* Wilcoxon Signed Ranks Test
tems.  This because for 20mm PMMA phantom doses are higher for DR than for SF.  
From our yearly and half yearly test results, we know that image quality in terms of 
contrast-to-noise ratio is much higher at 20mm PMMA than at larger thicknesses.  As 
the European Quality Control Protocol [4] demands a constant contrast-to-noise ratio 
for all thicknesses, there is a potential of dose reduction for DR-systems at smaller 
thicknesses.  Care must be taken that the overall contrast-to-noise level stays high 
enough to see small low-contrast details even in dense and thick breasts. 
Whether and to what extent the patient dose decreases or increases in an individual 
mammographic unit after digitalization therefore largely depends on the choice for 
CR or for DR and is also determined by the brand and type of the formerly used 
screen-film combination and x-ray unit. 
An increase of 38% in average glandular dose for the transition from SF to CR 
could change the detection over induction ratio (DIR) of the Flemish breast cancer 
program from 40 to 30 provided that the cancer detection rate stays the same.  There-
fore we plan to investigate for the same 49 mammography units, the impact of digital-
ization on the breast cancer screening performance parameters such as recall rate, 
cancer detection rate, fraction of invasive cancers, fraction of invasive cancers smaller 
than 1cm, fraction of ductal carcinoma in situ (DCIS) and the positive predictive val-
ue.  This in order to calculate the DIR for digital mammography screening in Flanders 
and to ensure the overall quality of the digitalized Flemish breast screening program. 
5 Conclusion 
In present study it was shown that transition from screen-film to digital mammogra-
phy will not necessarily result in a dose reduction.  In fact the use of computed radi-
ography leads to an important increase in average glandular dose (38%).  On the other 
hand direct digital mammography contributed to a small but significant decrease in 
average glandular dose (12%).  Direct digital mammography can be further optimized 
for smaller compressed breast thicknesses without compromising image quality.   
From patient dose point of view, direct digital mammography has to be preferred 
over computed radiography in digitalization of mammography screening.  A close 
collaboration between radiographers and medical physicists is indicated. 
Manufacturers of direct digital mammography systems are advised to investigate 
how the automatic exposure control can be further optimized for smaller thicknesses: 
care should be taken that clinical as well as physical image quality parameters meet 
all requirements in lowering the dose setting. 
Results obtained in present study are clearly in favor of direct digital radiography 
in digitalization of the screening program. 
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